Designing viral vector clearance studies for CGT products according to ICH Q5A (R2): part 1
Cell and Gene Therapy Insights 2023; 9(4), 2001
DOI: 10.18609/cgti.2023.067
Published: 19 May 2023
FastFacts
![]() | Watch the video or view the poster to learn more about:
|